West Coast Clinical Trials, LLC Expands Executive Team with New Hire
Yves Grenon, Vice President of Business Development and Strategic Planning

Cypress, CA / August 1, 2007 / - West Coast Clinical Trials, LLC (WCCT) (“WCCT”) adds a new member to its executive team – Yves Grenon, VP of Business Development. West Coast Clinical Trials is a growing Early Phase Clinical CRO and is proud to welcome him to their organization. Yves Grenon will lead the Business Development team and play a crucial role in the development of WCCT’s clinical research activities.

“Yves is a significant asset to West Coast Clinical Trials, LLC,” said Dr. Kenneth Kim, CEO and founder. “His 14 years of experience in the CRO industry will further increase the organization’s strength. In addition, Yves’ extensive intellectual knowledge will additionally integrate with the management team’s vision.”

Mr. Grenon has more than 14 years of drug development industry experience including international experience in Europe and Japan. Most recently, Mr. Grenon was the Executive Director of Business Development (Clinical & Bioanalytical Innovator Market), at Pharmanet, formerly SFBC International, where he developed key markets across US, Europe and Japan, and led the integration of 5 clinical and bioanalytical sites. Prior to Pharmanet, Mr. Grenon was the Senior Director of Business Development at MDS Pharma Services, a full-spectrum CRO, where he was responsible for the for the European market and later on the Japanese market. Over the years, Mr. Grenon has been successful in implementing new processes for the management of innovator drug markets.

Mr. Grenon holds a degree in life sciences and furthered his education in Management at McGill University, Montréal, Canada.

About West Coast Clinical Trials, LLC

WCCT is an Early Stage Clinical CRO, with full service capabilities. The company not only performs healthy volunteer studies, but has a unique differentiating feature of excelling in various ethno-bridging trials targeting specific ethnic groups ---Japanese bridging, Chinese bridging, Asian ethnicity, Hispanic, and African American focused studies. In addition, WCCT has expertise in a number of special population trials: allergy, asthma, renal impaired, platelet aggregometry, and pediatric trials.

For almost 10 years, WCCT has conducted hundreds of clinical studies involving thousands of patients for nationally and internationally recognized pharmaceutical companies.

WCCT’s mission is to deliver early phase clinical solutions for drug development with flexibility and responsiveness that meets our sponsors' unique needs. The company’s focus is to be the center of excellence for bridging medical research into new therapies that benefit lives. For more information, please visit www.wcctrials.com.

_____________________

Contact:


_____________________

Source: West Coast Clinical Trials, LLC